Tata Consumer, Navin Fluorine, Torrent Pharma, Havells India in focus

Tata Consumer Products: The company has ceased negotiations with Bisleri with regard to a potential transaction and to confirm that the company has not entered into any definitive agreement or binding commitment on this matter.

Navin Fluorine International: The board of Navin Fluorine Advanced Sciences (NFASL), a wholly owned subsidiary of the company has approved a capital expenditure of Rs 450 crore for setting up a new 40,000 tonnes per annum hydrofluoric acid capacity at Dahej.

Torrent Pharmaceuticals: The USFDA conducted Pre-Approval Inspection [PAI] of Oral-Oncology manufacturing facility at Bileshwarpura, Gujarat from 13 March 2023 to 17 March 2023. At the end of the inspection, it has issued a 'Form 483' with 1 observation, which is procedural in nature.

Havells India: The company has started commercial production of Air-Conditioners at its Sri-City plant, Chittoor District, Andhra Pradesh from 17 March 2023.

SKF India: The board of directors of the company has agreed to make an investment in M/s Cleanmax Taiyo Private Limited ('the Investee Company') by acquiring 2,600 fully paid up equity shares of Rs. 10/- each equivalent to 26% of the total issued and paid-up share capital of the Investee Company.

Rail Vikas Nigam Limited (RVNL): RVNL emerged as the Lowest Bidder (L1) for composite contract package in connection with new BG Railway Line of HORC project. The cost of project is Rs. 1088.49 crore.

Powered by Capital Market - Live News